Company intelligence / Profile preview

Advanced Bioadjuvants LLC

Omaha, Nebraska, United Statesadvancedbioadjuvants.com ↗

Ownership: Private
Development stage: Other

Overview

Advanced Bioadjuvants LLC develops and produces proprietary adjuvant formulations such as Adjuplex, which are used to enhance the effectiveness of vaccines. Their products have been referenced in government contracts for research purposes but there is no public record of clinical trial results in humans. The company appears active in supplying adjuvant technologies primarily for research, development, and possibly commercial use within agriculture or veterinary sectors rather than direct pharmaceutical applications.

Therapeutic areas: Other
Modalities: Adjuvants for vaccines and agricultural applications
Industry: Non-Drug Biotech

Partnerships

National Institute of Allergy and Infectious Diseases (NIAID) / Vaccine Research Center has procured their Adjuplex product for research purposes.

Beyond the preview

Go deeper on Advanced Bioadjuvants LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Bioadjuvants LLC.